Literature DB >> 444399

Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.

H H Wan, N Thatcher, P W Mullen, G N Smith, P M Wilkinson.   

Abstract

Serial serum diphenylhydantoin and urinary 5-(p-hydroxphenyl)-5-phenylhydantoin concentrations were determined in 8 patients with malignant disease and 4 healthy volunteers on 2 separate occasions after an oral dose of diphenylhydantoin (500 mg). No significant difference was observed between metabolism before and 10 days after immunization with BCG or Corynebacterium parvum. Volunteers without intervening immunization similarly showed no difference.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444399      PMCID: PMC2009933          DOI: 10.1038/bjc.1979.78

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum.

Authors:  L F Soyka; W G Hunt; S E Knight; R S Foster
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

2.  High-pressure liquid-chromatographic determination of 5-(4-hydroxyphenyl)-5-phenylhydantoin in humanurine.

Authors:  P M Kabra; L J Marton
Journal:  Clin Chem       Date:  1976-10       Impact factor: 8.327

3.  Effect of diphenylhydantoin on hepatic drug hydroxylation.

Authors:  F Petruch; R V Schüppel; G Steinhilber
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

4.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

5.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

6.  Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.

Authors:  D Farquhar; T L Loo; J U Gutterman; E M Hersh; M A Luna
Journal:  Biochem Pharmacol       Date:  1976-07-01       Impact factor: 5.858

7.  Letter: Corynebacterium parvum and anaesthetics.

Authors:  B Mosedale; M A Smith
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

8.  Comparative drug elimination in man-diphenylhydantoin and amobarbital.

Authors:  J F Brien; T Inaba; W Kalow
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

9.  Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.

Authors:  T C Sorrell; I J Forbes
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

10.  Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

Authors:  T C Sorrell; I J Forbes; F R Burness; R H Rischbieth
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

View more
  1 in total

1.  Interaction between immunologic and chemotherapeutic treatments.

Authors:  P W Mullen
Journal:  Can Med Assoc J       Date:  1982-10-01       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.